Bezuclastinib
Cogent Biosciences, Inc.
['dial']
we re excited to host a webcast today at 8:00am et to discuss the initial apex data reported this morning at #eha2022. for details and dial-in information, see our press release. 
Precision therapeutics for genetically defined diseases